SelectION

San Diego, CA · Founded 2002 · Privately Held (backing)

Developer of peptide therapeutics designed to assist in the treatment of autoimmune diseases and disorders. SelectION is based in San Diego, CA and was founded in 2002. Its last reported valuation was $195 million in Jun 2023. It has raised $19.6 million across 4 recorded rounds; the latest was a $5.4 million early-stage round in Sep 2025.

Last reported valuation
$195.0M
Oct 2026
Priced at
—
Total raised
$19.6M
Last round
Early Stage VC
Sep 2025

Who backs SelectION?

6 investors
InvestorType
Bay Area Biosciences Association—
BioM Biotech Cluster Development—
Bundesministerium für Bildung und Forschung—
Global Source Ventures—
Mey Capital Matrix—
SDL Ventures—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

SelectION investors

6 investors are on record for SelectION, including Bay Area Biosciences Association, BioM Biotech Cluster Development, Bundesministerium für Bildung und Forschung and Global Source Ventures. The early-stage round in Sep 2025 drew 5 investors.

Free account
More of SelectION with a free account
  • ·Watch SelectION: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 6 firms already write checks for companies like SelectION. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View